drugset / Trial / NCT00087984
RNA-Loaded Dendritic Cell Cancer Vaccine
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to examine the safety, feasibility, immunological response, and clinical antitumor activity of administering a dendritic cell vaccine to patients with metastatic renal cell carcinoma.
Timeline
- Start
- 2004-01
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MB-002 | Unknown | — | — |